AIMEE SCROGGS: Open Payments
NPI 1336556885 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,349 in 68 payments from 11 companies in 2025. Trend: 2023 $917 · 2024 $5,394 · 2025 $10,349
Food & beverage: $3,991Travel & lodging: $2,938Speaker / faculty: $1,800Consulting: $1,620
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 13 | $5,030 |
| Madrigal Pharmaceuticals | 34 | $3,779 |
| Gilead Sciences, Inc. | 10 | $460 |
| GENZYME CORPORATION | 2 | $230 |
| Novo Nordisk Inc | 3 | $180 |
| Medtronic, Inc. | 1 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Mirum Pharmaceuticals, Inc. | 1 | $114 |
| Intercept Pharmaceuticals, Inc. | 1 | $104 |
Products named: IQIRVO, REZDIFFRA, Wegovy, INTERSTIM, Kerendia, STRENSIQ, Bylvay, FABRAZYME.
Industry payments across LA — which companies pay providers there.
